Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI.

Storandt M, Grant EA, Miller JP, Morris JC.

Neurology. 2006 Aug 8;67(3):467-73.

PMID:
16894109
2.

Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Levey A, Lah J, Goldstein F, Steenland K, Bliwise D.

Clin Ther. 2006 Jul;28(7):991-1001. Review.

PMID:
16990077
3.

[Neuropsychological impairment in the early Alzheimer's disease].

Traykov L, Rigaud AS, Cesaro P, Boller F.

Encephale. 2007 May-Jun;33(3 Pt 1):310-6. Review. French.

PMID:
17675928
4.

Mild cognitive impairment: a clinically useful but currently ill-defined concept?

Thompson SA, Hodges JR.

Neurocase. 2002;8(6):405-10. Review.

PMID:
12529449
5.

[Limits and uncertainties about the concept of MCI: contribution of neuropsychological approach].

Laurent B, Thomas Antérion C.

Rev Neurol (Paris). 2002;158(10 Suppl):S11-20. Review. French.

PMID:
12529581
6.

Neuropathologic alterations in mild cognitive impairment: a review.

Markesbery WR.

J Alzheimers Dis. 2010;19(1):221-8. doi: 10.3233/JAD-2010-1220. Review.

7.

Vascular mild cognitive impairment: concept, definition, and directions for future studies.

Consoli A, Pasi M, Pantoni L.

Aging Clin Exp Res. 2012 Apr;24(2):113-6. Review.

PMID:
22842831
8.
9.

Rate of progression of mental decline in Alzheimer disease: summary of European studies.

Bracco L, Piccini C, Amaducci L.

Alzheimer Dis Assoc Disord. 1998 Dec;12(4):347-55. Review.

PMID:
9876964
Items per page

Supplemental Content

Support Center